World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
32909
World Ranking
16428
National Ranking
690

Martin Kolb publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Martin Kolb sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 504 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Martin Kolb D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Kolb sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Martin Kolb is affiliated with McMaster University in Canada and contributes extensively to the field of Medicine, particularly focusing on Pulmonary and Respiratory Medicine. Their research spans several specialized subfields including Physiology, Pathology and Forensic Medicine, Surgery, and Molecular Biology.

The main topics of their work encompass:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Medical Imaging and Pathology Studies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Occupational and Environmental Lung Diseases
  • Systemic Sclerosis and Related Diseases
  • Pulmonary Hypertension Research and Treatments

Martin Kolb has published frequently in several prestigious venues, with numerous contributions to:

  • European Respiratory Journal
  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • Annals of the American Thoracic Society
  • Respiratory Research

Their recent papers include:

  • "Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial" (2020) published in The Lancet Respiratory Medicine
  • "Idiopathic pulmonary fibrosis: state of the art for 2023" (2023) published in European Respiratory Journal
  • "Progressive pulmonary fibrosis: an expert group consensus statement" (2022) published in European Respiratory Journal
  • "The importance of interventional timing in the bleomycin model of pulmonary fibrosis" (2020) published in European Respiratory Journal
  • "Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study" (2022) published in The Lancet Respiratory Medicine

Frequent collaborators in Martin Kolb's research include:

  • Kerri A. Johannson
  • Christopher J. Ryerson
  • H. Manganas
  • Jolene H. Fisher
  • Nasreen Khalil

Best Publications

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

    Kevin R Flaherty;Athol U Wells;Kevin K Brown

  • Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Collard Hr;Ryerson Cj;Corte Tj;Jenkins G

  • The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

    Antje Moeller;Kjetil Ask;David Warburton;Jack Gauldie

  • Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

    Martin Kolb;Peter J. Margetts;Daniel C. Anthony;Fernando Pitossi

  • Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

    Lutz Wollin;Eva Wex;Alexander Pautsch;Gisela Schnapp

  • Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

    David J. Lederer;Scott C. Bell;Richard D. Branson;James D. Chalmers

  • Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

    Antje Moeller;Sarah E. Gilpin;Kjetil Ask;Gerard Cox

  • Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis

    Philippe Bonniaud;Martin Kolb;Martin Kolb;Tom Galt;Jennifer Robertson

  • Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Athol U. Wells;Kevin R. Flaherty;Kevin K. Brown;Yoshikazu Inoue

  • An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.

    R. Gisli Jenkins;Bethany B. Moore;Rachel C. Chambers;Oliver Eickelberg

  • Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung

    Martin Kolb;Peter J. Margetts;Patricia J. Sime;Jack Gauldie

  • Progressive Transforming Growth Factor β1–induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor

    Philippe Bonniaud;Peter J. Margetts;Martin Kolb;Jane Ann Schroeder

  • TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis

    Philippe Bonniaud;Peter J. Margetts;Kjetil Ask;Kathy Flanders

  • Gene Transfer of Transforming Growth Factor-β1 to the Rat Peritoneum: Effects on Membrane Function

    Peter J. Margetts;Martin Kolb;Tom Galt;Catherine M. Hoff

  • Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis

    Michael Kreuter;Svenja Ehlers-Tenenbaum;Karin Palmowski;Jacques Bruhwyler

  • Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin.

    Martin Kolb;Peter J. Margetts;T. O. M. Galt;Patricia J. Sime

  • What's in a name? That which we call IPF, by any other name would act the same.

    Athol U Wells;Kevin K Brown;Kevin R Flaherty;Martin Kolb

  • VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats

    Laszlo Farkas;Daniela Farkas;Kjetil Ask;Antje Möller

  • TGF-β, Smad3 and the process of progressive fibrosis

    J. Gauldie;P. Bonniaud;P. Sime;K. Ask

Frequent Co-Authors

Jack Gauldie
Jack Gauldie McMaster University
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Toby M. Maher
Toby M. Maher University of Southern California
Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Mark D. Inman
Mark D. Inman McMaster University
Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Ganesh Raghu
Ganesh Raghu University of Washington
Tobias Welte
Tobias Welte University of Hannover
Athol U. Wells
Athol U. Wells Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to a range of diverse healthcare careers. Many students seek alternative pathways that align with their interests and schedules. For example, nursing schools that don't require teas exams offer a more accessible route for aspiring nurses who may be concerned about standardized test requirements.

Healthcare management is another dynamic field. Program options like a healthcare administration degree online accredited let you study from anywhere, making it easier to balance education with existing work or life commitments.

If you’re already a registered nurse, advancing your career is possible through bridge programs such as adn to fnp programs, which help nurses become family nurse practitioners in a more streamlined way.

For those interested in preventive care and wellness, earning an online degree in nutrition may be a rewarding option. This field offers opportunities to work in clinical settings, public health, or private practice, empowering others to make healthier choices.

Best Scientists Citing Martin Kolb

Trending Scientists